chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Adult failure to thrive, Blood albumin decreased, Blood creatinine normal, Blood folate normal
Clinical narrative: Patient was hospitalized due to breakthrough infection. Patient received J&J vaccine on 04/07/2021. Patient was hospitalized from 01/03/2022 - 01/15/2022. Below is copied from discharge summary:  Hospital Course:   Patient is a 70 y/o F with Hx of Chronic HfpEF, CKD, IDDM2, leukemia, COPD, depression, recent covid 19, chronic hypoxic resp failure on home O2 2L, who presents via EMS due to SOB, found with increase lung opacities concerning for developing HAP, AMS and possibly UTI.    Acute encephalopathy: -Resolve -No distress noted, awake and oriented -Likely from COVID 19 -ABG wo increased CO2 -UA WNL -CT head, no acute changes -Continue OP follow up w PCP   Acute on chronic hypoxic respiratory failure 2/2 COVID 19/ On home O2: -Resolve -Non septic -Chest Xray showed worsening PNA -Completed decadron for 4 days -Resume statin -Suportive care   Possible HAP: -Better -Non septic -Procalcitonin 0.30 -CT chest reviewed -Completed abx tx   Complicated UTI / Hx of ESBL UTI and Pseudomonas UTI -UA with trace LE -Prior UC grew ESBL, E coli resistant to fluoroquinolonas and pansensitive Pseudomonas -Now UC 5,000 cfu -Completed abx tx   Normocytic anemia: -Stable -B12, folate WNL -Iron 19   FTT / Functional decline / Severe protein calorie malnutrition: -Alb 2.5 -Boost with meals -Dietitian consulted   Demand ischemia: -Trop 58, pending delta 0 -Non ischemic EKG   CKD: -Cr 1.1 -Monitor   HTN: -Stable -Resume home meds   Depression: -Resume SSRI   Hyperglycemia 2/2 uncontrolled IDDM2 with neuropathy: -Better -Resume insulin -SS and accuchecks -Resume gabapentin   COPD: -Stable -Resume home inhalers   CAD: -Resume asa and statin   Chronic HFPEF/AICD -Euvolemic   Leukemia: -s/p tx -F/U OPD with Heme/Onc     Patient is discharged in stable condition with stable vital signs. All questions rearding hospital course and plan of care after discharge have been answered to satisfaction. Prescriptions for medications needed to be taken after discharge have been given to patient. Patient has been instructed to follow up with PCP within the next 7 days after discharge. Patient verbalizes understanding all given instructions and has no further doubts regarding discharge.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Blood gases, Blood iron decreased, COVID-19, Carbon dioxide normal, Chest X-ray abnormal
Clinical narrative: Patient was hospitalized due to breakthrough infection. Patient received J&J vaccine on 04/07/2021. Patient was hospitalized from 01/03/2022 - 01/15/2022. Below is copied from discharge summary:  Hospital Course:   Patient is a 70 y/o F with Hx of Chronic HfpEF, CKD, IDDM2, leukemia, COPD, depression, recent covid 19, chronic hypoxic resp failure on home O2 2L, who presents via EMS due to SOB, found with increase lung opacities concerning for developing HAP, AMS and possibly UTI.    Acute encephalopathy: -Resolve -No distress noted, awake and oriented -Likely from COVID 19 -ABG wo increased CO2 -UA WNL -CT head, no acute changes -Continue OP follow up w PCP   Acute on chronic hypoxic respiratory failure 2/2 COVID 19/ On home O2: -Resolve -Non septic -Chest Xray showed worsening PNA -Completed decadron for 4 days -Resume statin -Suportive care   Possible HAP: -Better -Non septic -Procalcitonin 0.30 -CT chest reviewed -Completed abx tx   Complicated UTI / Hx of ESBL UTI and Pseudomonas UTI -UA with trace LE -Prior UC grew ESBL, E coli resistant to fluoroquinolonas and pansensitive Pseudomonas -Now UC 5,000 cfu -Completed abx tx   Normocytic anemia: -Stable -B12, folate WNL -Iron 19   FTT / Functional decline / Severe protein calorie malnutrition: -Alb 2.5 -Boost with meals -Dietitian consulted   Demand ischemia: -Trop 58, pending delta 0 -Non ischemic EKG   CKD: -Cr 1.1 -Monitor   HTN: -Stable -Resume home meds   Depression: -Resume SSRI   Hyperglycemia 2/2 uncontrolled IDDM2 with neuropathy: -Better -Resume insulin -SS and accuchecks -Resume gabapentin   COPD: -Stable -Resume home inhalers   CAD: -Resume asa and statin   Chronic HFPEF/AICD -Euvolemic   Leukemia: -s/p tx -F/U OPD with Heme/Onc     Patient is discharged in stable condition with stable vital signs. All questions rearding hospital course and plan of care after discharge have been answered to satisfaction. Prescriptions for medications needed to be taken after discharge have been given to patient. Patient has been instructed to follow up with PCP within the next 7 days after discharge. Patient verbalizes understanding all given instructions and has no further doubts regarding discharge.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chronic kidney disease, Computerised tomogram head normal, Computerised tomogram thorax, Condition aggravated, Culture urine
Clinical narrative: Patient was hospitalized due to breakthrough infection. Patient received J&J vaccine on 04/07/2021. Patient was hospitalized from 01/03/2022 - 01/15/2022. Below is copied from discharge summary:  Hospital Course:   Patient is a 70 y/o F with Hx of Chronic HfpEF, CKD, IDDM2, leukemia, COPD, depression, recent covid 19, chronic hypoxic resp failure on home O2 2L, who presents via EMS due to SOB, found with increase lung opacities concerning for developing HAP, AMS and possibly UTI.    Acute encephalopathy: -Resolve -No distress noted, awake and oriented -Likely from COVID 19 -ABG wo increased CO2 -UA WNL -CT head, no acute changes -Continue OP follow up w PCP   Acute on chronic hypoxic respiratory failure 2/2 COVID 19/ On home O2: -Resolve -Non septic -Chest Xray showed worsening PNA -Completed decadron for 4 days -Resume statin -Suportive care   Possible HAP: -Better -Non septic -Procalcitonin 0.30 -CT chest reviewed -Completed abx tx   Complicated UTI / Hx of ESBL UTI and Pseudomonas UTI -UA with trace LE -Prior UC grew ESBL, E coli resistant to fluoroquinolonas and pansensitive Pseudomonas -Now UC 5,000 cfu -Completed abx tx   Normocytic anemia: -Stable -B12, folate WNL -Iron 19   FTT / Functional decline / Severe protein calorie malnutrition: -Alb 2.5 -Boost with meals -Dietitian consulted   Demand ischemia: -Trop 58, pending delta 0 -Non ischemic EKG   CKD: -Cr 1.1 -Monitor   HTN: -Stable -Resume home meds   Depression: -Resume SSRI   Hyperglycemia 2/2 uncontrolled IDDM2 with neuropathy: -Better -Resume insulin -SS and accuchecks -Resume gabapentin   COPD: -Stable -Resume home inhalers   CAD: -Resume asa and statin   Chronic HFPEF/AICD -Euvolemic   Leukemia: -s/p tx -F/U OPD with Heme/Onc     Patient is discharged in stable condition with stable vital signs. All questions rearding hospital course and plan of care after discharge have been answered to satisfaction. Prescriptions for medications needed to be taken after discharge have been given to patient. Patient has been instructed to follow up with PCP within the next 7 days after discharge. Patient verbalizes understanding all given instructions and has no further doubts regarding discharge.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Diabetes mellitus inadequate control, Diabetic neuropathy, Dyspnoea, Electrocardiogram abnormal, Encephalopathy
Clinical narrative: Patient was hospitalized due to breakthrough infection. Patient received J&J vaccine on 04/07/2021. Patient was hospitalized from 01/03/2022 - 01/15/2022. Below is copied from discharge summary:  Hospital Course:   Patient is a 70 y/o F with Hx of Chronic HfpEF, CKD, IDDM2, leukemia, COPD, depression, recent covid 19, chronic hypoxic resp failure on home O2 2L, who presents via EMS due to SOB, found with increase lung opacities concerning for developing HAP, AMS and possibly UTI.    Acute encephalopathy: -Resolve -No distress noted, awake and oriented -Likely from COVID 19 -ABG wo increased CO2 -UA WNL -CT head, no acute changes -Continue OP follow up w PCP   Acute on chronic hypoxic respiratory failure 2/2 COVID 19/ On home O2: -Resolve -Non septic -Chest Xray showed worsening PNA -Completed decadron for 4 days -Resume statin -Suportive care   Possible HAP: -Better -Non septic -Procalcitonin 0.30 -CT chest reviewed -Completed abx tx   Complicated UTI / Hx of ESBL UTI and Pseudomonas UTI -UA with trace LE -Prior UC grew ESBL, E coli resistant to fluoroquinolonas and pansensitive Pseudomonas -Now UC 5,000 cfu -Completed abx tx   Normocytic anemia: -Stable -B12, folate WNL -Iron 19   FTT / Functional decline / Severe protein calorie malnutrition: -Alb 2.5 -Boost with meals -Dietitian consulted   Demand ischemia: -Trop 58, pending delta 0 -Non ischemic EKG   CKD: -Cr 1.1 -Monitor   HTN: -Stable -Resume home meds   Depression: -Resume SSRI   Hyperglycemia 2/2 uncontrolled IDDM2 with neuropathy: -Better -Resume insulin -SS and accuchecks -Resume gabapentin   COPD: -Stable -Resume home inhalers   CAD: -Resume asa and statin   Chronic HFPEF/AICD -Euvolemic   Leukemia: -s/p tx -F/U OPD with Heme/Onc     Patient is discharged in stable condition with stable vital signs. All questions rearding hospital course and plan of care after discharge have been answered to satisfaction. Prescriptions for medications needed to be taken after discharge have been given to patient. Patient has been instructed to follow up with PCP within the next 7 days after discharge. Patient verbalizes understanding all given instructions and has no further doubts regarding discharge.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperglycaemia, Loss of personal independence in daily activities, Lung opacity, Malnutrition, Myocardial ischaemia
Clinical narrative: Patient was hospitalized due to breakthrough infection. Patient received J&J vaccine on 04/07/2021. Patient was hospitalized from 01/03/2022 - 01/15/2022. Below is copied from discharge summary:  Hospital Course:   Patient is a 70 y/o F with Hx of Chronic HfpEF, CKD, IDDM2, leukemia, COPD, depression, recent covid 19, chronic hypoxic resp failure on home O2 2L, who presents via EMS due to SOB, found with increase lung opacities concerning for developing HAP, AMS and possibly UTI.    Acute encephalopathy: -Resolve -No distress noted, awake and oriented -Likely from COVID 19 -ABG wo increased CO2 -UA WNL -CT head, no acute changes -Continue OP follow up w PCP   Acute on chronic hypoxic respiratory failure 2/2 COVID 19/ On home O2: -Resolve -Non septic -Chest Xray showed worsening PNA -Completed decadron for 4 days -Resume statin -Suportive care   Possible HAP: -Better -Non septic -Procalcitonin 0.30 -CT chest reviewed -Completed abx tx   Complicated UTI / Hx of ESBL UTI and Pseudomonas UTI -UA with trace LE -Prior UC grew ESBL, E coli resistant to fluoroquinolonas and pansensitive Pseudomonas -Now UC 5,000 cfu -Completed abx tx   Normocytic anemia: -Stable -B12, folate WNL -Iron 19   FTT / Functional decline / Severe protein calorie malnutrition: -Alb 2.5 -Boost with meals -Dietitian consulted   Demand ischemia: -Trop 58, pending delta 0 -Non ischemic EKG   CKD: -Cr 1.1 -Monitor   HTN: -Stable -Resume home meds   Depression: -Resume SSRI   Hyperglycemia 2/2 uncontrolled IDDM2 with neuropathy: -Better -Resume insulin -SS and accuchecks -Resume gabapentin   COPD: -Stable -Resume home inhalers   CAD: -Resume asa and statin   Chronic HFPEF/AICD -Euvolemic   Leukemia: -s/p tx -F/U OPD with Heme/Onc     Patient is discharged in stable condition with stable vital signs. All questions rearding hospital course and plan of care after discharge have been answered to satisfaction. Prescriptions for medications needed to be taken after discharge have been given to patient. Patient has been instructed to follow up with PCP within the next 7 days after discharge. Patient verbalizes understanding all given instructions and has no further doubts regarding discharge.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Normocytic anaemia, Pneumonia, Procalcitonin, Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: Patient was hospitalized due to breakthrough infection. Patient received J&J vaccine on 04/07/2021. Patient was hospitalized from 01/03/2022 - 01/15/2022. Below is copied from discharge summary:  Hospital Course:   Patient is a 70 y/o F with Hx of Chronic HfpEF, CKD, IDDM2, leukemia, COPD, depression, recent covid 19, chronic hypoxic resp failure on home O2 2L, who presents via EMS due to SOB, found with increase lung opacities concerning for developing HAP, AMS and possibly UTI.    Acute encephalopathy: -Resolve -No distress noted, awake and oriented -Likely from COVID 19 -ABG wo increased CO2 -UA WNL -CT head, no acute changes -Continue OP follow up w PCP   Acute on chronic hypoxic respiratory failure 2/2 COVID 19/ On home O2: -Resolve -Non septic -Chest Xray showed worsening PNA -Completed decadron for 4 days -Resume statin -Suportive care   Possible HAP: -Better -Non septic -Procalcitonin 0.30 -CT chest reviewed -Completed abx tx   Complicated UTI / Hx of ESBL UTI and Pseudomonas UTI -UA with trace LE -Prior UC grew ESBL, E coli resistant to fluoroquinolonas and pansensitive Pseudomonas -Now UC 5,000 cfu -Completed abx tx   Normocytic anemia: -Stable -B12, folate WNL -Iron 19   FTT / Functional decline / Severe protein calorie malnutrition: -Alb 2.5 -Boost with meals -Dietitian consulted   Demand ischemia: -Trop 58, pending delta 0 -Non ischemic EKG   CKD: -Cr 1.1 -Monitor   HTN: -Stable -Resume home meds   Depression: -Resume SSRI   Hyperglycemia 2/2 uncontrolled IDDM2 with neuropathy: -Better -Resume insulin -SS and accuchecks -Resume gabapentin   COPD: -Stable -Resume home inhalers   CAD: -Resume asa and statin   Chronic HFPEF/AICD -Euvolemic   Leukemia: -s/p tx -F/U OPD with Heme/Onc     Patient is discharged in stable condition with stable vital signs. All questions rearding hospital course and plan of care after discharge have been answered to satisfaction. Prescriptions for medications needed to be taken after discharge have been given to patient. Patient has been instructed to follow up with PCP within the next 7 days after discharge. Patient verbalizes understanding all given instructions and has no further doubts regarding discharge.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Troponin increased, Urinary tract infection, Urine leukocyte esterase positive, Vaccine breakthrough infection, Vitamin B12 normal
Clinical narrative: Patient was hospitalized due to breakthrough infection. Patient received J&J vaccine on 04/07/2021. Patient was hospitalized from 01/03/2022 - 01/15/2022. Below is copied from discharge summary:  Hospital Course:   Patient is a 70 y/o F with Hx of Chronic HfpEF, CKD, IDDM2, leukemia, COPD, depression, recent covid 19, chronic hypoxic resp failure on home O2 2L, who presents via EMS due to SOB, found with increase lung opacities concerning for developing HAP, AMS and possibly UTI.    Acute encephalopathy: -Resolve -No distress noted, awake and oriented -Likely from COVID 19 -ABG wo increased CO2 -UA WNL -CT head, no acute changes -Continue OP follow up w PCP   Acute on chronic hypoxic respiratory failure 2/2 COVID 19/ On home O2: -Resolve -Non septic -Chest Xray showed worsening PNA -Completed decadron for 4 days -Resume statin -Suportive care   Possible HAP: -Better -Non septic -Procalcitonin 0.30 -CT chest reviewed -Completed abx tx   Complicated UTI / Hx of ESBL UTI and Pseudomonas UTI -UA with trace LE -Prior UC grew ESBL, E coli resistant to fluoroquinolonas and pansensitive Pseudomonas -Now UC 5,000 cfu -Completed abx tx   Normocytic anemia: -Stable -B12, folate WNL -Iron 19   FTT / Functional decline / Severe protein calorie malnutrition: -Alb 2.5 -Boost with meals -Dietitian consulted   Demand ischemia: -Trop 58, pending delta 0 -Non ischemic EKG   CKD: -Cr 1.1 -Monitor   HTN: -Stable -Resume home meds   Depression: -Resume SSRI   Hyperglycemia 2/2 uncontrolled IDDM2 with neuropathy: -Better -Resume insulin -SS and accuchecks -Resume gabapentin   COPD: -Stable -Resume home inhalers   CAD: -Resume asa and statin   Chronic HFPEF/AICD -Euvolemic   Leukemia: -s/p tx -F/U OPD with Heme/Onc     Patient is discharged in stable condition with stable vital signs. All questions rearding hospital course and plan of care after discharge have been answered to satisfaction. Prescriptions for medications needed to be taken after discharge have been given to patient. Patient has been instructed to follow up with PCP within the next 7 days after discharge. Patient verbalizes understanding all given instructions and has no further doubts regarding discharge.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Cerebrovascular accident, Computerised tomogram, Fibrin D dimer, Magnetic resonance imaging
Clinical narrative: STROKE
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: not known, unable to reach case/POA
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Feeling abnormal, Myalgia, Respiratory tract congestion
Clinical narrative: Temperature,  muscle aches, joint pain, brain fog, congestion
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Myocarditis, Pericarditis, Troponin increased
Clinical narrative: myocarditis/pericarditis
Age: 89.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acute kidney injury, Blood calcium decreased, Blood urea increased, COVID-19, Chest X-ray normal
Clinical narrative: Patient was hospitalized due to breakthrough infection. Patient received Pfizer vaccine (2nd dose in series) on 04/06/2021. Patient was hospitalized from 01/07/2022 - 01/20/2022. Below is copied from discharge summary:  Hospital Course:  Patient is a 90 y/o F with Hx of dementia, hypothyroidism, HTN, HLD and GERD who presents from Nursing and Rehab who presents due to abnormal labs today-BUN of 90, admitted as OBS for further management.   # AKI on CKD -In context of Covid 19  -Gentle hydration in setting of concomitant HF  -Avoid nephrotoxins   #COVID 19: - Stable with low flow O2 by NC - Isolation, stop steroids - followed closely    # L pleural effusion: -Small - Monitored     # Leukocytosis: -WBC of 14 -Steroid related ? -Afebrile -Xray w/o new infiltrate -UA/UCx pending -Monitor off Abx     Hypocalcemia: -7.8 - Corrects with alb  -Monitor   HLD: -Resume statin   Neuropathy: -Resume gabapentin   Hypothyroidism: -Resume synthroid   GERD: -Resume ppi   Dementia: -Supportive care   Moderate protein calorie malnutrition  -BMI of 16 -Start supplement    discussed with patient's daughter over the phone. Comfort care. No blood draws.   Consulted hospice   To SNF with hospice following
Age: 89.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chronic kidney disease, Culture urine, Hypocalcaemia, Leukocytosis, Malnutrition
Clinical narrative: Patient was hospitalized due to breakthrough infection. Patient received Pfizer vaccine (2nd dose in series) on 04/06/2021. Patient was hospitalized from 01/07/2022 - 01/20/2022. Below is copied from discharge summary:  Hospital Course:  Patient is a 90 y/o F with Hx of dementia, hypothyroidism, HTN, HLD and GERD who presents from Nursing and Rehab who presents due to abnormal labs today-BUN of 90, admitted as OBS for further management.   # AKI on CKD -In context of Covid 19  -Gentle hydration in setting of concomitant HF  -Avoid nephrotoxins   #COVID 19: - Stable with low flow O2 by NC - Isolation, stop steroids - followed closely    # L pleural effusion: -Small - Monitored     # Leukocytosis: -WBC of 14 -Steroid related ? -Afebrile -Xray w/o new infiltrate -UA/UCx pending -Monitor off Abx     Hypocalcemia: -7.8 - Corrects with alb  -Monitor   HLD: -Resume statin   Neuropathy: -Resume gabapentin   Hypothyroidism: -Resume synthroid   GERD: -Resume ppi   Dementia: -Supportive care   Moderate protein calorie malnutrition  -BMI of 16 -Start supplement    discussed with patient's daughter over the phone. Comfort care. No blood draws.   Consulted hospice   To SNF with hospice following
Age: 89.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Neuropathy peripheral, Pleural effusion, SARS-CoV-2 test positive, Urine analysis, Vaccine breakthrough infection
Clinical narrative: Patient was hospitalized due to breakthrough infection. Patient received Pfizer vaccine (2nd dose in series) on 04/06/2021. Patient was hospitalized from 01/07/2022 - 01/20/2022. Below is copied from discharge summary:  Hospital Course:  Patient is a 90 y/o F with Hx of dementia, hypothyroidism, HTN, HLD and GERD who presents from Nursing and Rehab who presents due to abnormal labs today-BUN of 90, admitted as OBS for further management.   # AKI on CKD -In context of Covid 19  -Gentle hydration in setting of concomitant HF  -Avoid nephrotoxins   #COVID 19: - Stable with low flow O2 by NC - Isolation, stop steroids - followed closely    # L pleural effusion: -Small - Monitored     # Leukocytosis: -WBC of 14 -Steroid related ? -Afebrile -Xray w/o new infiltrate -UA/UCx pending -Monitor off Abx     Hypocalcemia: -7.8 - Corrects with alb  -Monitor   HLD: -Resume statin   Neuropathy: -Resume gabapentin   Hypothyroidism: -Resume synthroid   GERD: -Resume ppi   Dementia: -Supportive care   Moderate protein calorie malnutrition  -BMI of 16 -Start supplement    discussed with patient's daughter over the phone. Comfort care. No blood draws.   Consulted hospice   To SNF with hospice following
Age: 89.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: White blood cell count increased
Clinical narrative: Patient was hospitalized due to breakthrough infection. Patient received Pfizer vaccine (2nd dose in series) on 04/06/2021. Patient was hospitalized from 01/07/2022 - 01/20/2022. Below is copied from discharge summary:  Hospital Course:  Patient is a 90 y/o F with Hx of dementia, hypothyroidism, HTN, HLD and GERD who presents from Nursing and Rehab who presents due to abnormal labs today-BUN of 90, admitted as OBS for further management.   # AKI on CKD -In context of Covid 19  -Gentle hydration in setting of concomitant HF  -Avoid nephrotoxins   #COVID 19: - Stable with low flow O2 by NC - Isolation, stop steroids - followed closely    # L pleural effusion: -Small - Monitored     # Leukocytosis: -WBC of 14 -Steroid related ? -Afebrile -Xray w/o new infiltrate -UA/UCx pending -Monitor off Abx     Hypocalcemia: -7.8 - Corrects with alb  -Monitor   HLD: -Resume statin   Neuropathy: -Resume gabapentin   Hypothyroidism: -Resume synthroid   GERD: -Resume ppi   Dementia: -Supportive care   Moderate protein calorie malnutrition  -BMI of 16 -Start supplement    discussed with patient's daughter over the phone. Comfort care. No blood draws.   Consulted hospice   To SNF with hospice following
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain
Clinical narrative: Moderate chest pain, especially when breathing. Tylenol helps mildly with the pain.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Exposure via breast milk, Fatigue, Headache, Injection site pain
Clinical narrative: Fever: 105F going up and down; chills; sore throat; headache;  muscle weakness; pain at site of the shot; fatigue. I?m breastfeeding and my baby got fever too.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Muscular weakness, Oropharyngeal pain, Pyrexia
Clinical narrative: Fever: 105F going up and down; chills; sore throat; headache;  muscle weakness; pain at site of the shot; fatigue. I?m breastfeeding and my baby got fever too.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Headache, Illness, Maternal exposure during breast feeding, Nausea
Clinical narrative: I received my second dose of the Moderna Covid vaccine on Thursday and was incredibly sick by 2am Friday which lasted through Saturday until 2pm. My symptoms were to be expected: nausea, body aches, fever, headache, stomach cramps. The biggest issue that was not expected is my milk supply has drastically decreased to where today baby isn?t able to get any milk and screaming when I put him to breastfeed. I?m trying to pump all day long and not producing any. I was overproducing 20-25oz a day  by catching in haakaa, not even pumping. I had a seamless breastfeeding journey so far and he?s gaining rapidly and was eating 4oz+ a feed. He was born 10/18/21 so he?s 3 months old. I?m not having to give him the frozen milk since I?m not producing any. Nothing else has changed, I?m still in maternity leave, eating healthy and drinking tons of fluids.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Suppressed lactation
Clinical narrative: I received my second dose of the Moderna Covid vaccine on Thursday and was incredibly sick by 2am Friday which lasted through Saturday until 2pm. My symptoms were to be expected: nausea, body aches, fever, headache, stomach cramps. The biggest issue that was not expected is my milk supply has drastically decreased to where today baby isn?t able to get any milk and screaming when I put him to breastfeed. I?m trying to pump all day long and not producing any. I was overproducing 20-25oz a day  by catching in haakaa, not even pumping. I had a seamless breastfeeding journey so far and he?s gaining rapidly and was eating 4oz+ a feed. He was born 10/18/21 so he?s 3 months old. I?m not having to give him the frozen milk since I?m not producing any. Nothing else has changed, I?m still in maternity leave, eating healthy and drinking tons of fluids.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Fall, Syncope
Clinical narrative: shortly after receiving the vaccine, as patient was leaving, she told her mother, she was going to pass out - then she passed out and fell to the floor. a cool pack was applied and juice given.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Acidosis, Acute respiratory failure, Aspiration, Bronchial secretion retention, Bronchoscopy abnormal
Clinical narrative: Patient is DECEASED.  Hospitalized (12.19.21-1.17.2022); COVID-19 positive (1.6.22);  Fully vaccinated (no booster) Admission Date: 12/19/2021 Discharge Date: 1/17/2021   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Diabetic foot  Non-healing ulcer of left foot, unspecified ulcer stage  PAD  COVID  Acute ischemic stroke HOSPITAL COURSE: Patient had a history of severe peripheral vascular disease and was status post LLE balloon angioplasty on 12/28 as well as metatarsal amputation secondary to osteomyelitis on 1/4. Patient was initially under the service of General Medicine from 12/19/21-1/11/22 for care of these medical conditions. On 1/11/22 he was then admitted to the Medical Intensive Care Unit in the setting of acute hypoxic hypercapnic respiratory failure likely secondary to COVID-19 infection requiring intubation and hemodynamic support.  While admitted to the MICU, patient continued to receive IV antibiotics at for continued coverage of osteomyelitis per recommendations of infectious disease colleagues. He was given steroids and lung protective ventilation for COVID pneumonitis. His respiratory status improved with decreasing FiO2 requirements and sufficient intrinsic respiratory effort on spontaneous breathing trial to the point that he was successfully extubated on 1/16. Throughout the night of 1/16 however, patient had several episodes of respiratory distress with hypoxia which required he be placed on BiPAP for continued respiratory support. Repeat Chest X-rays following extubation showed evolving left lung consolidation which progressed to complete opacification of the left hemithorax. Given the chronicity and unilateral nature of the opacity, this was thought to be secondary to mucus plugging rather than a pleural effusion. Patient was alert and oriented at this time with wife at the bedside, patient confirmed goals of care and consented to therapeutic bronchoscopy. Bronchoscopy was successfully performed on the afternoon of 1/17 with evidence of significant mucus plugging of left main bronchus. CXR post-procedure showed improved aeration throughout the left lung field.  However, later in the afternoon on 1/17, MICU physician team was urgently called to the bedside at 16:56. Patient was found to be in PEA arrest and profoundly acidotic. He was intubated and resuscitated per protocol with 4x attempts to contact family. Repeat bronchoscopy confirmed a significant aspiration event as the likely cause of this arrest. Patient again arrested at 17:39, initial rhythm showed PEA. CPR was again initiated and protocol was followed. MICU fellow was able to get ahold of patient's daughter at this time and decision was made to discontinue further resuscitation efforts in the setting of several arrests with poor prognosis. Further resuscitation was then discontinued and patient expired shortly after.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Cardiac arrest, Chest X-ray abnormal, Condition aggravated
Clinical narrative: Patient is DECEASED.  Hospitalized (12.19.21-1.17.2022); COVID-19 positive (1.6.22);  Fully vaccinated (no booster) Admission Date: 12/19/2021 Discharge Date: 1/17/2021   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Diabetic foot  Non-healing ulcer of left foot, unspecified ulcer stage  PAD  COVID  Acute ischemic stroke HOSPITAL COURSE: Patient had a history of severe peripheral vascular disease and was status post LLE balloon angioplasty on 12/28 as well as metatarsal amputation secondary to osteomyelitis on 1/4. Patient was initially under the service of General Medicine from 12/19/21-1/11/22 for care of these medical conditions. On 1/11/22 he was then admitted to the Medical Intensive Care Unit in the setting of acute hypoxic hypercapnic respiratory failure likely secondary to COVID-19 infection requiring intubation and hemodynamic support.  While admitted to the MICU, patient continued to receive IV antibiotics at for continued coverage of osteomyelitis per recommendations of infectious disease colleagues. He was given steroids and lung protective ventilation for COVID pneumonitis. His respiratory status improved with decreasing FiO2 requirements and sufficient intrinsic respiratory effort on spontaneous breathing trial to the point that he was successfully extubated on 1/16. Throughout the night of 1/16 however, patient had several episodes of respiratory distress with hypoxia which required he be placed on BiPAP for continued respiratory support. Repeat Chest X-rays following extubation showed evolving left lung consolidation which progressed to complete opacification of the left hemithorax. Given the chronicity and unilateral nature of the opacity, this was thought to be secondary to mucus plugging rather than a pleural effusion. Patient was alert and oriented at this time with wife at the bedside, patient confirmed goals of care and consented to therapeutic bronchoscopy. Bronchoscopy was successfully performed on the afternoon of 1/17 with evidence of significant mucus plugging of left main bronchus. CXR post-procedure showed improved aeration throughout the left lung field.  However, later in the afternoon on 1/17, MICU physician team was urgently called to the bedside at 16:56. Patient was found to be in PEA arrest and profoundly acidotic. He was intubated and resuscitated per protocol with 4x attempts to contact family. Repeat bronchoscopy confirmed a significant aspiration event as the likely cause of this arrest. Patient again arrested at 17:39, initial rhythm showed PEA. CPR was again initiated and protocol was followed. MICU fellow was able to get ahold of patient's daughter at this time and decision was made to discontinue further resuscitation efforts in the setting of several arrests with poor prognosis. Further resuscitation was then discontinued and patient expired shortly after.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Coronary angioplasty, Death, Diabetic foot, Endotracheal intubation, Hypoxia
Clinical narrative: Patient is DECEASED.  Hospitalized (12.19.21-1.17.2022); COVID-19 positive (1.6.22);  Fully vaccinated (no booster) Admission Date: 12/19/2021 Discharge Date: 1/17/2021   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Diabetic foot  Non-healing ulcer of left foot, unspecified ulcer stage  PAD  COVID  Acute ischemic stroke HOSPITAL COURSE: Patient had a history of severe peripheral vascular disease and was status post LLE balloon angioplasty on 12/28 as well as metatarsal amputation secondary to osteomyelitis on 1/4. Patient was initially under the service of General Medicine from 12/19/21-1/11/22 for care of these medical conditions. On 1/11/22 he was then admitted to the Medical Intensive Care Unit in the setting of acute hypoxic hypercapnic respiratory failure likely secondary to COVID-19 infection requiring intubation and hemodynamic support.  While admitted to the MICU, patient continued to receive IV antibiotics at for continued coverage of osteomyelitis per recommendations of infectious disease colleagues. He was given steroids and lung protective ventilation for COVID pneumonitis. His respiratory status improved with decreasing FiO2 requirements and sufficient intrinsic respiratory effort on spontaneous breathing trial to the point that he was successfully extubated on 1/16. Throughout the night of 1/16 however, patient had several episodes of respiratory distress with hypoxia which required he be placed on BiPAP for continued respiratory support. Repeat Chest X-rays following extubation showed evolving left lung consolidation which progressed to complete opacification of the left hemithorax. Given the chronicity and unilateral nature of the opacity, this was thought to be secondary to mucus plugging rather than a pleural effusion. Patient was alert and oriented at this time with wife at the bedside, patient confirmed goals of care and consented to therapeutic bronchoscopy. Bronchoscopy was successfully performed on the afternoon of 1/17 with evidence of significant mucus plugging of left main bronchus. CXR post-procedure showed improved aeration throughout the left lung field.  However, later in the afternoon on 1/17, MICU physician team was urgently called to the bedside at 16:56. Patient was found to be in PEA arrest and profoundly acidotic. He was intubated and resuscitated per protocol with 4x attempts to contact family. Repeat bronchoscopy confirmed a significant aspiration event as the likely cause of this arrest. Patient again arrested at 17:39, initial rhythm showed PEA. CPR was again initiated and protocol was followed. MICU fellow was able to get ahold of patient's daughter at this time and decision was made to discontinue further resuscitation efforts in the setting of several arrests with poor prognosis. Further resuscitation was then discontinued and patient expired shortly after.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Impaired healing, Intensive care, Ischaemic stroke, Lung consolidation, Lung opacity
Clinical narrative: Patient is DECEASED.  Hospitalized (12.19.21-1.17.2022); COVID-19 positive (1.6.22);  Fully vaccinated (no booster) Admission Date: 12/19/2021 Discharge Date: 1/17/2021   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Diabetic foot  Non-healing ulcer of left foot, unspecified ulcer stage  PAD  COVID  Acute ischemic stroke HOSPITAL COURSE: Patient had a history of severe peripheral vascular disease and was status post LLE balloon angioplasty on 12/28 as well as metatarsal amputation secondary to osteomyelitis on 1/4. Patient was initially under the service of General Medicine from 12/19/21-1/11/22 for care of these medical conditions. On 1/11/22 he was then admitted to the Medical Intensive Care Unit in the setting of acute hypoxic hypercapnic respiratory failure likely secondary to COVID-19 infection requiring intubation and hemodynamic support.  While admitted to the MICU, patient continued to receive IV antibiotics at for continued coverage of osteomyelitis per recommendations of infectious disease colleagues. He was given steroids and lung protective ventilation for COVID pneumonitis. His respiratory status improved with decreasing FiO2 requirements and sufficient intrinsic respiratory effort on spontaneous breathing trial to the point that he was successfully extubated on 1/16. Throughout the night of 1/16 however, patient had several episodes of respiratory distress with hypoxia which required he be placed on BiPAP for continued respiratory support. Repeat Chest X-rays following extubation showed evolving left lung consolidation which progressed to complete opacification of the left hemithorax. Given the chronicity and unilateral nature of the opacity, this was thought to be secondary to mucus plugging rather than a pleural effusion. Patient was alert and oriented at this time with wife at the bedside, patient confirmed goals of care and consented to therapeutic bronchoscopy. Bronchoscopy was successfully performed on the afternoon of 1/17 with evidence of significant mucus plugging of left main bronchus. CXR post-procedure showed improved aeration throughout the left lung field.  However, later in the afternoon on 1/17, MICU physician team was urgently called to the bedside at 16:56. Patient was found to be in PEA arrest and profoundly acidotic. He was intubated and resuscitated per protocol with 4x attempts to contact family. Repeat bronchoscopy confirmed a significant aspiration event as the likely cause of this arrest. Patient again arrested at 17:39, initial rhythm showed PEA. CPR was again initiated and protocol was followed. MICU fellow was able to get ahold of patient's daughter at this time and decision was made to discontinue further resuscitation efforts in the setting of several arrests with poor prognosis. Further resuscitation was then discontinued and patient expired shortly after.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Mechanical ventilation, Osteomyelitis, Peripheral arterial occlusive disease, Positive airway pressure therapy, Pulseless electrical activity
Clinical narrative: Patient is DECEASED.  Hospitalized (12.19.21-1.17.2022); COVID-19 positive (1.6.22);  Fully vaccinated (no booster) Admission Date: 12/19/2021 Discharge Date: 1/17/2021   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Diabetic foot  Non-healing ulcer of left foot, unspecified ulcer stage  PAD  COVID  Acute ischemic stroke HOSPITAL COURSE: Patient had a history of severe peripheral vascular disease and was status post LLE balloon angioplasty on 12/28 as well as metatarsal amputation secondary to osteomyelitis on 1/4. Patient was initially under the service of General Medicine from 12/19/21-1/11/22 for care of these medical conditions. On 1/11/22 he was then admitted to the Medical Intensive Care Unit in the setting of acute hypoxic hypercapnic respiratory failure likely secondary to COVID-19 infection requiring intubation and hemodynamic support.  While admitted to the MICU, patient continued to receive IV antibiotics at for continued coverage of osteomyelitis per recommendations of infectious disease colleagues. He was given steroids and lung protective ventilation for COVID pneumonitis. His respiratory status improved with decreasing FiO2 requirements and sufficient intrinsic respiratory effort on spontaneous breathing trial to the point that he was successfully extubated on 1/16. Throughout the night of 1/16 however, patient had several episodes of respiratory distress with hypoxia which required he be placed on BiPAP for continued respiratory support. Repeat Chest X-rays following extubation showed evolving left lung consolidation which progressed to complete opacification of the left hemithorax. Given the chronicity and unilateral nature of the opacity, this was thought to be secondary to mucus plugging rather than a pleural effusion. Patient was alert and oriented at this time with wife at the bedside, patient confirmed goals of care and consented to therapeutic bronchoscopy. Bronchoscopy was successfully performed on the afternoon of 1/17 with evidence of significant mucus plugging of left main bronchus. CXR post-procedure showed improved aeration throughout the left lung field.  However, later in the afternoon on 1/17, MICU physician team was urgently called to the bedside at 16:56. Patient was found to be in PEA arrest and profoundly acidotic. He was intubated and resuscitated per protocol with 4x attempts to contact family. Repeat bronchoscopy confirmed a significant aspiration event as the likely cause of this arrest. Patient again arrested at 17:39, initial rhythm showed PEA. CPR was again initiated and protocol was followed. MICU fellow was able to get ahold of patient's daughter at this time and decision was made to discontinue further resuscitation efforts in the setting of several arrests with poor prognosis. Further resuscitation was then discontinued and patient expired shortly after.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory distress, Respiratory failure, Resuscitation, SARS-CoV-2 test positive, Skin ulcer
Clinical narrative: Patient is DECEASED.  Hospitalized (12.19.21-1.17.2022); COVID-19 positive (1.6.22);  Fully vaccinated (no booster) Admission Date: 12/19/2021 Discharge Date: 1/17/2021   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Diabetic foot  Non-healing ulcer of left foot, unspecified ulcer stage  PAD  COVID  Acute ischemic stroke HOSPITAL COURSE: Patient had a history of severe peripheral vascular disease and was status post LLE balloon angioplasty on 12/28 as well as metatarsal amputation secondary to osteomyelitis on 1/4. Patient was initially under the service of General Medicine from 12/19/21-1/11/22 for care of these medical conditions. On 1/11/22 he was then admitted to the Medical Intensive Care Unit in the setting of acute hypoxic hypercapnic respiratory failure likely secondary to COVID-19 infection requiring intubation and hemodynamic support.  While admitted to the MICU, patient continued to receive IV antibiotics at for continued coverage of osteomyelitis per recommendations of infectious disease colleagues. He was given steroids and lung protective ventilation for COVID pneumonitis. His respiratory status improved with decreasing FiO2 requirements and sufficient intrinsic respiratory effort on spontaneous breathing trial to the point that he was successfully extubated on 1/16. Throughout the night of 1/16 however, patient had several episodes of respiratory distress with hypoxia which required he be placed on BiPAP for continued respiratory support. Repeat Chest X-rays following extubation showed evolving left lung consolidation which progressed to complete opacification of the left hemithorax. Given the chronicity and unilateral nature of the opacity, this was thought to be secondary to mucus plugging rather than a pleural effusion. Patient was alert and oriented at this time with wife at the bedside, patient confirmed goals of care and consented to therapeutic bronchoscopy. Bronchoscopy was successfully performed on the afternoon of 1/17 with evidence of significant mucus plugging of left main bronchus. CXR post-procedure showed improved aeration throughout the left lung field.  However, later in the afternoon on 1/17, MICU physician team was urgently called to the bedside at 16:56. Patient was found to be in PEA arrest and profoundly acidotic. He was intubated and resuscitated per protocol with 4x attempts to contact family. Repeat bronchoscopy confirmed a significant aspiration event as the likely cause of this arrest. Patient again arrested at 17:39, initial rhythm showed PEA. CPR was again initiated and protocol was followed. MICU fellow was able to get ahold of patient's daughter at this time and decision was made to discontinue further resuscitation efforts in the setting of several arrests with poor prognosis. Further resuscitation was then discontinued and patient expired shortly after.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Toe amputation
Clinical narrative: Patient is DECEASED.  Hospitalized (12.19.21-1.17.2022); COVID-19 positive (1.6.22);  Fully vaccinated (no booster) Admission Date: 12/19/2021 Discharge Date: 1/17/2021   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Diabetic foot  Non-healing ulcer of left foot, unspecified ulcer stage  PAD  COVID  Acute ischemic stroke HOSPITAL COURSE: Patient had a history of severe peripheral vascular disease and was status post LLE balloon angioplasty on 12/28 as well as metatarsal amputation secondary to osteomyelitis on 1/4. Patient was initially under the service of General Medicine from 12/19/21-1/11/22 for care of these medical conditions. On 1/11/22 he was then admitted to the Medical Intensive Care Unit in the setting of acute hypoxic hypercapnic respiratory failure likely secondary to COVID-19 infection requiring intubation and hemodynamic support.  While admitted to the MICU, patient continued to receive IV antibiotics at for continued coverage of osteomyelitis per recommendations of infectious disease colleagues. He was given steroids and lung protective ventilation for COVID pneumonitis. His respiratory status improved with decreasing FiO2 requirements and sufficient intrinsic respiratory effort on spontaneous breathing trial to the point that he was successfully extubated on 1/16. Throughout the night of 1/16 however, patient had several episodes of respiratory distress with hypoxia which required he be placed on BiPAP for continued respiratory support. Repeat Chest X-rays following extubation showed evolving left lung consolidation which progressed to complete opacification of the left hemithorax. Given the chronicity and unilateral nature of the opacity, this was thought to be secondary to mucus plugging rather than a pleural effusion. Patient was alert and oriented at this time with wife at the bedside, patient confirmed goals of care and consented to therapeutic bronchoscopy. Bronchoscopy was successfully performed on the afternoon of 1/17 with evidence of significant mucus plugging of left main bronchus. CXR post-procedure showed improved aeration throughout the left lung field.  However, later in the afternoon on 1/17, MICU physician team was urgently called to the bedside at 16:56. Patient was found to be in PEA arrest and profoundly acidotic. He was intubated and resuscitated per protocol with 4x attempts to contact family. Repeat bronchoscopy confirmed a significant aspiration event as the likely cause of this arrest. Patient again arrested at 17:39, initial rhythm showed PEA. CPR was again initiated and protocol was followed. MICU fellow was able to get ahold of patient's daughter at this time and decision was made to discontinue further resuscitation efforts in the setting of several arrests with poor prognosis. Further resuscitation was then discontinued and patient expired shortly after.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Agitation, Dizziness, Dyspnoea, Lymphadenopathy, Nausea
Clinical narrative: Pt came in. said she had no  reaction  until 1 week after her first shot, but wanted to get her second shot. She said she had swelling under arm, but said positive it was not lymph nodes, and some tightness around chin  for very short time,  and nausea for 1 month.  She said sister had same rxn but on 2nd shot had no rxn whatever, so wanted to get it. We discussed it, and I told her at least make sure you have benadryl and someone around you at all times since it was so much later rxn time if at all, than the shot, not sure if it even came from the shot except possibly the swelling under arm.  She said she understood.  5 minutes after getting the shot, during her 15 minute waiting period, she said she felt tightening in her larynx and was having trouble breathing. Gave her 50mg benadryl and called 911. While waiting for rescue squad, she said she was feeling dizzy, but she was also getting more agitated and breathing fast and deep. I told her to slow down, breath slowly and calmly. When rescue squad arrived they took over. Talked to her but she got more agitated again and they started oxygen, but only used it for about 5 minutes. They took it off, she was conscious the entire time, and they told her they wanted to transport her to ER for observation only. She stood up and got onto the gurney herself.  Tried to call her at 6pm but no answer.